Inside Reproductive Health Podcast

Game-changing innovation doesn’t happen by accident.  It happens when the best minds in fertility are constantly testing, improving, and challenging what’s possible.  We dive into this notion with Dr. Rita Vassena, Medical Director of Fertility at CooperSurgical. She spends her time visiting high-performing IVF labs around the world, identifying the technologies, processes, and ideas that are shap...

Is PGT as we know it coming to an end? Drs. Arlene Morales, Holly Mehr & Drew Tortoriello discuss what they see as the next evolution of PGT and why whole genome sequencing could reshape the future of embryo testing. They dive into: Why all PGT could include whole genome sequencing within five years Concerns about PGT-P and direct-to-consumer marketing What they want to hear from ASRM and othe...

Third-party IVF is getting bigger, but are clinics actually getting better at it? Or are some efforts to streamline the process creating new risks for patients? Dr. Allison Bloom of Main Line Fertility and Dr. Daniel Shapiro of Reproductive Biology Associates (RBA) discuss what separates a clinic that offers third-party reproduction from one that truly excels at it. We dive into: The push to strea...

More than half of IVF patients never complete treatment.  Stress, finances, and relationship strain may play a role, but are fertility workflows optimized for cycles completed over families built also to blame? In this episode, leaders from Inception Fertility share how they’re using technology, workflow design, and operational strategy to improve the patient journey from first inquiry through gra...

Cyber threats in fertility aren’t abstract, they're active and closer than most clinics think. And with AI lowering the barrier, even inexperienced actors can cause serious damage. In this episode of Inside Reproductive Health , One Stop IT experts Chris Diamond and Jordan Spriegel share what’s really happening and how fertility centers can respond. How cyber attackers infiltrate fertility and...

Genetic testing in IVF is only getting more complex and more common. REIs, you’re not supposed to do this alone, help is already here. We speak with four genetic counselors, Amber Kaplun, Rachel Donnell, Andria Besser, and Lauri Black, about how this works in practice. We dive into: How to embed genetic counselors into your workflow How to free up REI time while improving patient experience Why ac...

What is CCRM building toward, and how are they preparing for what comes next? As part of Unified Women’s Healthcare, CCRM is positioning for a future where “hub and spoke” becomes more than just a buzzword. Tracy Belsan, President of CCRM Fertility, joins the episode to share how they’re thinking about growth, operations, and the patient journey. We dive into: The KPIs CCRM focuses on The operatio...

A tale of two PGTs. One is making bold promises and headlines, the other is quietly gaining traction and relevance. Between PGT-P & PGT-G…what’s actually moving the needle? Dr. Mili Thakur of Genome Ally and Dr. Sasha Hakman of HRC Fertility break down what they’re seeing in real patients, especially when everything else has already failed. We dive into: The real difference between PGT-P and P...

The results are in: 5 healthy babies born, 64.3% fertilization rate, zero eggs damaged across hundreds of oocytes. Lab automation in IVF is no longer theoretical, it’s been proven. Chief Scientific Officers Jason Barritt of Kindbody and Jacques Cohen of Conceivable Life Sciences join the episode to discuss a recent study published in Human Reproduction examining AURA , the robotic lab system devel...

Do fertility doctors deserve happiness? It sounds like a strange question, but for many REIs it’s not abstract. We step back from operations, technology, and finance to ask a more fundamental question with Inception’s National Medical Director, Dr. Jason Yeh: What does a good life actually look like for a fertility specialist? In this conversation, we explore: Moral injury vs. burnout The X–Y axis...

What are the drug makers up to? And who’s about to win or lose in fertility pharmacy? This final category overview takes a hard look at the shifting pharmaceutical landscape of legacy manufacturers, rising challengers, supplement disruptors, and the latest in professional services. We also dive into: Why the pharmacy “middle” may be hollowed out Which models are positioned to scale ( and which are...

Patients want clearer pricing, clinics want operational sustainability, managed care wants predictable cost control… …and everyone wants more transparency. This epiosde centers on the groundbreaking Journal of Assisted Reproduction and Genetics (JARG) paper on Activity-Based Costing in IVF and what it actually costs. We’re joined by Pinnacle CFO Shruti Sood, The Fertility Partners CEO Heather Star...

Clinics are feeling the pressure.  And one year after the PGT class action lawsuits, the ripple effects are still unfolding. We’re back with another Fertility Field Overview, and this one looks at what’s happening across patient finance, IVF benefits and third-party reproduction, genetics and diagnostics, and the evolving self-pay landscape. We discuss: Whether IVF benefits managers are helping cl...

Patients, providers, and staff are doing far too much manual work, and with today’s tech it’s time to operationalize. This Fertility Field Overview breaks down the current state of AI-enabled operations, patient journey software, device innovation, cryo safety… …and where the field is falling behind. This episode covers: My bold prediction regarding IVI RMA’s approach to tech adoption ( Hint: Thin...

“Everyone in our class is freaking out right now…” That’s the text I got from a fellow last year during the Park City retreat. In this episode, I break down the state of fertility center networks in 2026, based on what I’m hearing directly from physicians, operators, and investors across the field. This is not sponsored commentary, and none of the organizations mentioned had editorial control or p...

For more than a decade, the debate around PGT has felt like the same arguments, the same uncertainty, and little change in day-to-day clinical decision-making. So what’s different now? Joining the conversation are two REIs, Dr. Deirdre Conway of Utah Fertility Center and Dr. Meera Shah of Nova IVF. Together they examine how recent events, emerging data, and evolving lab practices are reshaping how...

As Boston IVF becomes part of a much larger organization, a natural question emerges:  Does a legacy brand get diluted, or does its history shape what comes next? In this episode, Dr. Alan Penzias reflects on Boston IVF’s deep roots and how that heritage continues to influence the organization’s future within the RMA network. The conversation covers: Boston IVF’s founding history and the leaders w...

The gap between provider care and financial counseling may be costing you patients. This episode focuses on that gap. Joining the conversation are Dr. Allison Bloom, practicing REI at Main Line Fertility, and Cheryl Campbell, Director of Operations at BUNDL. Together they examine: Where the clinical care and financial counseling should intersect Why patients fall out of care between the provider v...

How do large fertility networks retain great people when everyone is struggling to do the same? In this week’s episode of Inside Reproductive Health , Iris González, Chief Operating Officer of IVI RMA North America, to talks about how one of the largest fertility organizations in the country approaches retention, leadership, and patient experience at scale. Iris shares: How IVI RMA uses regular op...

How much does an IVF cycle cost? Seems like a simple question. But as this week’s guests explain, it’s not. The way most of us account for “an IVF cycle” hides how many individual work orders and variables are actually involved. That lack of clarity can distort cost, efficiency, and strategy. This week on Inside Reproductive Health , Griffin talks with Steve Rooks, co-author of a groundbreaking pa...

“They expect us to be perfect.” That’s how Dr. Jamie Grifo, Chief Executive Physician of the Inception/Prelude Network, describes the expectations placed on reproductive endocrinologists from patients, payors, and policymakers alike. And while perfection may be impossible, preparation and partnership aren’t. He discusses: – Why NYU Langone has three in-house genetic counselors in their REI departm...

Embryologists have a lot riding on the line. Bad supplies can cause big problems. Good supplies can create big improvements. Either way, success rates and patients’ lives hang in the balance. Every detail in the IVF lab matters.  “Good enough” can cost more than it saves, because only the highest standards protect consistency, outcomes and trust..    We’re joined this week by two of the most respe...

How are clinicians doing? Patients are expecting more, offering less gratitude, and leaving negative reviews faster than ever. Sound familiar? Dr. Alice Domar, Chief Compassion Officer at Inception, talks about the emotional toll of working in reproductive medicine and what can be done about it. Dr. Domar shares: – Practical strategies for burnout prevention – The one small intervention proven to...

What will the IVF lab look like in five years? Trying to predict and shape that response is Dr. Denny Sakkas, Chief Scientific Officer at Boston IVF and head of the scientific advisory board for AutoIVF. In this episode of Inside Reproductive Health , Dr. Sakkas about what automation really means for embryologists, and how new technologies could transform lab operations, chain of custody, and pati...

Lab directors, how do you make sure your concerns actually reach ownership? Vendors, how are you being vetted by the groups you serve? This week on Inside Reproductive Health , Amy Jones, Chief Quality Officer of Ivy Fertility, talks about how one of the country’s leading networks evaluates quality, chooses partners, and plans for growth. Amy shares: – The specific criteria Ivy uses to vet vendors...